Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Covance Receives 2019 Global CRO Customer Value Leadership Award from Frost & Sullivan
  • USA - English


News provided by

Frost & Sullivan

20 Nov, 2019, 13:17 IST

Share this article

Share toX

Share this article

Share toX

SINGAPORE, Nov. 20, 2019 /PRNewswire/ -- Covance was honored with the 2019 Global CRO Customer Value Leadership award from Frost & Sullivan at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held in Singapore on 14 November 2019.

Frost & Sullivan firmly believes Covance's end-to-end drug development and commercialization solutions characterize its leadership in the highly dynamic CRO market.

Aarti Chitale, Senior Research Analyst, Life Sciences, Frost & Sullivan noted Covance aided the commercialization of the top 50 drugs worldwide, and enjoys a keen competitive edge in the CRO industry as reflected by strong financial performance.

"Covance's reach across more than 100 countries and a strong client base has helped to establish it as a leading global CRO. The company's cutting-edge services, including the Xcellerate® Informatics Suite designed to support all aspects of drug development services, has also created a strong branding among customers," she added.

"We are honored to work with some of the most innovative companies in the world, who are driving global advances in precision medicine," said Paul Kirchgraber, M.D., CEO, Covance. "Whether they need regional services and insight or support with a global strategy, Covance can provide data-driven solutions and significant expertise to drug development at every touchpoint. I appreciate our customers for giving us the opportunity to do what we do best. I am proud of our employees who consistently strive to improve health and improve lives."

The recipients of the annual Frost & Sullivan Asia-Pacific Best Practice Awards were identified based on in-depth research conducted by Frost & Sullivan's analysts. The award categories offered each year are carefully reviewed and evaluated to reflect the current market landscape and new emerging trends. The short-listed companies were evaluated on a variety of actual market performance indicators which include revenue growth, existing and growing market share, leadership in product innovation, and strategy in marketing and business development.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Media Contact

Melissa Tan
Corporate Communications – Asia-Pacific
Phone: +65.6890.0926
Email: [email protected]

Related Links

http://www.frost.com

Modal title

Also from this source

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated ...

Frost & Sullivan: UFODRIVE Receives the 2025 European New Mobility and Automotive Technology Innovation Leadership Recognition for Enhancing Customer Impact through Digital Innovation

Frost & Sullivan is pleased to announce that UFODRIVE has received the 2025 European New Mobility and Automotive Technology Innovation Leadership...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.